AD
Baloxavir Marboxil Impurity 22(CAS: 1370250-39-7)
CAS Number
Related Products
![(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate](https://static.chemtradehub.com/structs/144/144689-63-4-8851.webp)
![4-Chloro-2-[(2-furylmethyl)amino]-5-sulfamoylbenzoic acid](https://static.chemtradehub.com/structs/54-/54-31-9-70ce.webp)
![2-[(R)-{[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl}sulfinyl]-1H-benzimidazole](https://static.chemtradehub.com/structs/138/138530-94-6-bd58.webp)
![Ethyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate](https://static.chemtradehub.com/structs/144/144690-33-5-3c95.webp)
![Diethyl {2-[methoxy(methyl)amino]-2-oxoethyl}phosphonate](https://static.chemtradehub.com/structs/124/124931-12-0-3024.webp)
Other Suppliers for Baloxavir Marboxil Impurity 22
Basic Information
Molecular Formula
C17H17N3O4
Molecular Weight
327.34 g/mol
Chemical Identifiers
SMILES
c1ccc(cc1)COc2c(=O)ccn3c2C(=O)N4CCOCC4N3
InChIKey
HJTRSKVIYMCKJU-UHFFFAOYSA-N
Database References
MDL Number
MFCD31706264
FAQ
Baloxavir Marboxil Impurity 22 (CAS: 1370250-39-7) is a byproduct of the synthesis of baloxavir marboxil, a flu antiviral medication. It is an organic compound with potential pharmaceutical applications but is not used in the final formulation of baloxavir marboxil.
Baloxavir Marboxil Impurity 22 (CAS: 1370250-39-7) is primarily used in the development and quality control processes of baloxavir marboxil. It is not used in the final product but is monitored for safety and purity.
Baloxavir Marboxil Impurity 22 (CAS: 1370250-39-7) is generally considered safe under proper handling and storage conditions. However, it is important to follow safety guidelines and use appropriate protective equipment when working with this compound.
Baloxavir Marboxil Impurity 22 (CAS: 1370250-39-7) should be stored in a cool, dry place away from direct sunlight and heat sources. It should be kept in a sealed container to prevent degradation. Proper labeling and documentation are also recommended for traceability and safety.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Zhou Chao
sale01@hnrxpharm.com